Eucalyptus
Eucalyptus globulus
Eucalyptus oil and its main component 1,8-cineole (eucalyptol) have good controlled-trial support for bronchitis, sinusitis and COPD when taken as standardized capsules, while inhalation and chest rubs are popular but less proven.
At a Glance
- Best known for
- Oral cineole capsules reduce exacerbations in COPD and speed bronchitis recovery (RCTs), Thins mucus and improves sinus drainage (secretolytic), Anti-inflammatory action in the airways (reduces cytokines)
- Evidence
- Moderate
- Typical dose
- 200 mg cineole 3x daily for 7–10 days
- Type
- Herb
What is Eucalyptus?
Eucalyptus is a genus of over 700 Australian trees; Eucalyptus globulus (Tasmanian blue gum) is the main medicinal species, cultivated worldwide for its oil. Aboriginal Australians used the leaves for wounds and fevers, and from the 1850s eucalyptus oil became a staple of Western pharmacies for colds, coughs and as an antiseptic. Its key constituent, 1,8-cineole, is also the main component of cajeput and niaouli oils and appears in rosemary and bay. In Germany a purified cineole capsule (Soledum) is a licensed medicine for sinusitis, bronchitis and COPD, giving eucalyptus a stronger clinical base than most essential oils. The characteristic sharp scent is familiar from chest rubs, cough drops and saunas.
Known Health Benefits
How It Works
Cineole thins bronchial secretions by stimulating the mucus-producing glands and ciliary activity, improving clearance of phlegm from the airways and sinuses. It has documented anti-inflammatory effects in human lung cells and in patients, reducing TNF-α, IL-1β, IL-6 and leukotriene production from monocytes, which is thought to underlie the reduced COPD exacerbations in trials. Cineole also mildly relaxes bronchial smooth muscle and blocks some airway spasm. Topically it produces cooling then warming sensations, increases local blood flow and has analgesic effects through TRPM8 and TRPA1 channel modulation. Eucalyptus oil is antimicrobial against a range of bacteria and fungi and is a registered insect repellent (lemon eucalyptus oil, a different species, is the EPA-registered form).
What Research Says
The strongest evidence concerns purified cineole capsules. A 2009 randomized, placebo-controlled trial in 242 COPD patients found 200 mg cineole three times daily for 6 months reduced exacerbation frequency, severity and duration and improved lung function and quality of life. A 2013 placebo-controlled trial in 242 patients with acute bronchitis found cineole produced significantly greater improvement in cough frequency and bronchitis scores after 4 days. A 2004 trial in 152 patients with acute non-purulent sinusitis showed symptom scores fell significantly more with cineole than placebo over 7 days, and a 2014 trial in asthma patients found cineole allowed reduced steroid use. Evidence for steam inhalation and chest rubs is weaker: a Cochrane review of steam inhalation for colds found no clear benefit, and chest-rub trials in children show improved sleep but rely on parental report. Topical eucalyptus for pain has small supportive trials. Toxicology data are robust, with eucalyptus oil a leading cause of essential-oil poisoning in children.
Active Compounds
1,8-cineole (eucalyptol, 60–90% of E. globulus oil), α-pinene, limonene, α-terpineol; leaf tannins, flavonoids and macrocarpals
Forms & Bioavailability
Cineole is lipophilic and absorbed rapidly from the gut and lungs, peaking within 1–2 hours, and is measurable in exhaled breath, which supports a direct airway effect. It is metabolized by CYP enzymes (which it also induces) and excreted mostly in urine. Enteric-coated capsules reduce belching and reflux. Inhalation delivers cineole to the upper airways but systemic amounts are small; topical application through the skin is significant enough that large-area use can cause toxicity, especially in children. Tea delivers mainly tannins and flavonoids with modest cineole.
Dosage Guidance
| Use Case | Dosage |
|---|---|
| Acute bronchitis / sinusitis (adults) | 200 mg cineole 3x daily for 7–10 days |
| COPD exacerbation prevention | 200 mg cineole 3x daily long-term |
| Steam inhalation | 3–5 drops essential oil in a bowl of hot water, inhale 5–10 min up to 3x daily |
| Topical for muscle/joint pain | 2–5% oil in carrier oil, applied to area 2–3x daily |
| Leaf tea | 1–2 g dried leaf in 150 mL hot water, up to 3x daily |
Always consult a healthcare provider for personalized dosing.
Natural Food Sources
- Eucalyptus honey (from bee foraging; contains negligible cineole)
- Cough drops and lozenges (flavoring and active)
- Eucalyptus leaf tea (traditional)
- Trace flavoring in some confectionery
Potential Side Effects
Oral cineole capsules: mild GI upset, heartburn; undiluted or excessive essential oil: nausea, vomiting, dizziness, drowsiness, seizures and respiratory depression (as little as 3–5 mL can be seriously toxic, especially in children); skin irritation with topical use; laryngospasm in infants exposed near the face
Who Should Avoid It
- Children under 6 — essential oil (internal or near the face) risks laryngospasm, seizures and poisoning; cineole capsules not licensed
- Never ingest undiluted essential oil at any age
- Asthma with hypersensitivity to strong scents (inhalation may trigger bronchospasm in some)
- Severe liver disease (CYP effects)
- Inflammatory GI or biliary disease (cineole capsules)
- Epilepsy (cineole in large doses is pro-convulsant)
Pregnancy & Lactation
Eucalyptus leaf tea in small amounts and well-diluted topical oil are generally considered acceptable in pregnancy, but oral cineole capsules and essential oil ingestion are not recommended because safety data are lacking and cineole crosses the placenta. During breastfeeding, avoid applying eucalyptus oil to the chest or breast area where the infant could inhale or ingest it; oral capsule use is not studied and best avoided.
Known Drug Interactions
Cineole induces liver CYP enzymes (CYP1A2, 2C9, 3A4) and may lower levels of drugs such as some anticonvulsants and sedatives; additive effects with other CNS depressants; may lower blood sugar in animal studies (monitor with diabetes drugs); topical oil increases absorption of other topical drugs
Evidence Classification
Supported by cohort studies, case-control studies, or multiple observational studies with consistent findings.
Frequently Asked Questions
Is eucalyptus oil the same as the cineole capsules used in trials?
Not quite. The trials used pharmaceutical-grade purified 1,8-cineole (eucalyptol) in enteric-coated capsules at 200 mg three times daily. Eucalyptus essential oil is 60–90% cineole plus other terpenes and is not standardized or formulated for internal use. Do not try to replicate the capsule dose by swallowing essential oil; the capsules are available in Europe and as supplements elsewhere.
Do eucalyptus chest rubs help a child's cold?
One trial of a menthol-camphor-eucalyptus rub found parents reported better sleep and less cough in children over 2, though the strong smell makes true blinding impossible. Rubs are reasonable for children over 2 applied to the chest, never under the nose or on broken skin. Avoid all eucalyptus products in infants, and never apply oil near a young child's face.
How dangerous is swallowing eucalyptus oil?
Quite dangerous. Eucalyptus oil is among the most common essential-oil poisonings reported to poison centers, and as little as 2–3 mL has caused serious symptoms in children, with drowsiness, vomiting, seizures and breathing problems. Keep bottles out of reach, use child-resistant caps, and call poison control immediately after any ingestion.
Can eucalyptus help COPD?
The 6-month randomized trial of cineole capsules in COPD found about one-third fewer exacerbations and small improvements in lung function and quality of life, which is a meaningful result. It is used as an add-on to standard inhaler therapy in Germany. Anyone with COPD should discuss it with their respiratory physician rather than substituting it for prescribed treatment.
References
- Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: a placebo-controlled double-blind trial. Worth H, Schacher C, Dethlefsen U. Respir Res (2009)
- Efficacy of cineole in patients suffering from acute bronchitis: a placebo-controlled double-blind trial. Fischer J, Dethlefsen U. Cough (2013)
- Heated, humidified air for the common cold. Singh M, Singh M, Jaiswal N, Chauhan A. Cochrane Database Syst Rev (2017)
Related Health Conditions
Related Supplements
Have questions about Eucalyptus?
Ask Mother Nature AI about dosing, interactions with your medications, whether it fits your health goals, and more — personalized to your health profile.
This entry is for educational purposes only. It is not medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement regimen, especially if you take medications or have health conditions.